Baecher-Allan C M, Barth R K
University of Rochester Cancer Center, NY 14642.
Reg Immunol. 1993 May-Aug;5(3-4):207-17.
Susceptibility of mice to the induction of pulmonary fibrosis by bleomycin sulfate is inbred strain dependent, with C57BL/6 mice exhibiting high sensitivity to the drug and BALB/c mice demonstrating a resistant phenotype. The lungs of bleomycin treated C57BL/6J and BALB/cBy mice were analyzed for their mRNA expression level of a panel of cytokines using a semi-quantitative polymerase chain reaction (SQ-PCR) assay. Transforming growth factor-beta 1 (TGF-beta 1) mRNA was found to increase sevenfold by 5 days after bleomycin treatment of C57BL/6J (sensitive) mice. BALB/cBy (resistant) animals demonstrated a lower level of TGF-beta 1 mRNA induction, approximately threefold, after bleomycin administration. Analysis of interleukin-1 beta (IL-1 beta) mRNA levels also revealed a difference between the two strains, with BALB/cBy mice expressing approximately fourfold higher IL-1 beta mRNA levels than C57BL/6J mice. This result suggested possible protection by IL-1 beta. Analysis of (C57BL/6JxBALB/cBy)F1 hybrids, which are shown in this report to be sensitive to bleomycin-induced fibrosis, revealed a high IL-1 beta mRNA level, similar to that in the resistant parent. Thus, the observed strain variation in the level of IL-1 beta mRNA is not associated with differences in susceptibility to the induction of pulmonary fibrosis. In contrast, strain variation in interleukin-6 (IL-6) mRNA levels was observed that was completely concordant with the segregation of susceptibility phenotypes between the parental and F1 strains. This result indicates a possible association between sensitivity to bleomycin-induced fibrosis and inducibility of IL-6 mRNA upon drug treatment. Analysis of TGF-beta 2, interferon-gamma, interleukin-2, interleukin-3, and interleukin-4 (IL-4) mRNA showed no detectable strain variation in steady state mRNA levels in the lung as a consequence of bleomycin treatment. In contrast, the level of IL-4 receptor mRNA was induced to a higher degree in both sensitive groups (C57BL/6J and F1) than in resistant mice (BALB/cBy). Therefore, modulation of the IL-4 response, not at the level of IL-4 but through regulation of the IL-4 receptor, may play a role in pulmonary fibrogenesis.
小鼠对博来霉素诱导肺纤维化的易感性具有近交系依赖性,C57BL/6小鼠对该药物表现出高敏感性,而BALB/c小鼠则表现出抗性表型。使用半定量聚合酶链反应(SQ-PCR)分析方法,检测了博来霉素处理后的C57BL/6J和BALB/cBy小鼠肺组织中一组细胞因子的mRNA表达水平。发现博来霉素处理C57BL/6J(敏感)小鼠5天后,转化生长因子-β1(TGF-β1)mRNA增加了7倍。博来霉素给药后,BALB/cBy(抗性)小鼠的TGF-β1 mRNA诱导水平较低,约为3倍。白细胞介素-1β(IL-1β)mRNA水平分析也显示出两品系间存在差异,BALB/cBy小鼠表达的IL-1β mRNA水平比C57BL/6J小鼠高约4倍。这一结果提示IL-1β可能具有保护作用。对(C57BL/6JxBALB/cBy)F1杂种小鼠(本报告显示其对博来霉素诱导的纤维化敏感)的分析显示,其IL-1β mRNA水平较高,与抗性亲代相似。因此,观察到的IL-1β mRNA水平的品系差异与肺纤维化诱导易感性的差异无关。相反,观察到白细胞介素-6(IL-6)mRNA水平的品系差异与亲代和F1品系间易感性表型的分离完全一致。这一结果表明,对博来霉素诱导纤维化的敏感性与药物处理后IL-6 mRNA的诱导性之间可能存在关联。对TGF-β2、干扰素-γ、白细胞介素-2、白细胞介素-3和白细胞介素-4(IL-4)mRNA的分析显示,博来霉素处理后,肺组织中稳态mRNA水平未检测到品系差异。相反,敏感组(C57BL/6J和F1)中IL-4受体mRNA的诱导程度高于抗性小鼠(BALB/cBy)。因此,调节IL-4反应可能不是在IL-4水平,而是通过调节IL-4受体,在肺纤维化形成中发挥作用。